Sulodexide modifies intravascular homeostasis what affects function of the endothelium

A. Połubińska, R. Staniszewski, E. Baum, K. Sumińska-Jasińska, A. Brȩborowicz

Research output: Contribution to journalArticle

10 Citations (Scopus)

Abstract

Purpose: Sulodexide is a mixture of heparin and dermatan sulphate which has an antithrombotic action. It was shown that it has also direct effect on the endothelial cells. We tested the effect of sulodexide on the intravascular homeostasis in patients with peripheral vascular disease. Methods: Sulodexide was infused iv. at a dose of 1200 Lipoprotein Lipase Releasing Units (LRU) in 10 patients with peripheral vascular disease. Blood samples were collected before the infusion and 1, 6 and 24 hours after the infusion. Inflammatory and fibrinolytic parameters were studied in the collected serum samples. Additionally, ex-vivo effect of the serum samples on in vitro function of the endothelial cells was studied. Results: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium. We found that HGF enhanced in vitro stimulating effect of VEGF on proliferation of the endothelial cells. Serum level of interleukin-6 was gradually decreased, whereas fibrinolytic activity of serum, reflected by t-PA/PAI-1 ratio, increased. Serum samples obtained from the studied patients suppressed oxidative stress and release of interleukin-6 in endothelial cells maintained in in vitro culture. Conclusion: Sulodexide reduces intravascular inflammation and suppresses inflammatory reaction in the endothelial cells; both effects are desirable in patients with peripheral vascular disease.

Original languageEnglish (US)
Pages (from-to)304-310
Number of pages7
JournalAdvances in Medical Sciences
Volume58
Issue number2
DOIs
StatePublished - Dec 1 2013
Externally publishedYes

Fingerprint

Endothelium
Homeostasis
Endothelial Cells
Peripheral Vascular Diseases
Vascular Endothelial Growth Factor A
Serum
Hepatocyte Growth Factor
Interleukin-6
Dermatan Sulfate
Lipoprotein Lipase
Plasminogen Activator Inhibitor 1
Adsorption
Heparin
Oxidative Stress
glucuronyl glucosamine glycan sulfate
Inflammation
In Vitro Techniques

Keywords

  • Endothelium
  • Inflammation
  • Peripheral vascular disease
  • Sulodexide

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Połubińska, A., Staniszewski, R., Baum, E., Sumińska-Jasińska, K., & Brȩborowicz, A. (2013). Sulodexide modifies intravascular homeostasis what affects function of the endothelium. Advances in Medical Sciences, 58(2), 304-310. https://doi.org/10.2478/ams-2013-0016

Sulodexide modifies intravascular homeostasis what affects function of the endothelium. / Połubińska, A.; Staniszewski, R.; Baum, E.; Sumińska-Jasińska, K.; Brȩborowicz, A.

In: Advances in Medical Sciences, Vol. 58, No. 2, 01.12.2013, p. 304-310.

Research output: Contribution to journalArticle

Połubińska, A, Staniszewski, R, Baum, E, Sumińska-Jasińska, K & Brȩborowicz, A 2013, 'Sulodexide modifies intravascular homeostasis what affects function of the endothelium', Advances in Medical Sciences, vol. 58, no. 2, pp. 304-310. https://doi.org/10.2478/ams-2013-0016
Połubińska A, Staniszewski R, Baum E, Sumińska-Jasińska K, Brȩborowicz A. Sulodexide modifies intravascular homeostasis what affects function of the endothelium. Advances in Medical Sciences. 2013 Dec 1;58(2):304-310. https://doi.org/10.2478/ams-2013-0016
Połubińska, A. ; Staniszewski, R. ; Baum, E. ; Sumińska-Jasińska, K. ; Brȩborowicz, A. / Sulodexide modifies intravascular homeostasis what affects function of the endothelium. In: Advances in Medical Sciences. 2013 ; Vol. 58, No. 2. pp. 304-310.
@article{db045e75c66441f0b724af2516c59a85,
title = "Sulodexide modifies intravascular homeostasis what affects function of the endothelium",
abstract = "Purpose: Sulodexide is a mixture of heparin and dermatan sulphate which has an antithrombotic action. It was shown that it has also direct effect on the endothelial cells. We tested the effect of sulodexide on the intravascular homeostasis in patients with peripheral vascular disease. Methods: Sulodexide was infused iv. at a dose of 1200 Lipoprotein Lipase Releasing Units (LRU) in 10 patients with peripheral vascular disease. Blood samples were collected before the infusion and 1, 6 and 24 hours after the infusion. Inflammatory and fibrinolytic parameters were studied in the collected serum samples. Additionally, ex-vivo effect of the serum samples on in vitro function of the endothelial cells was studied. Results: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium. We found that HGF enhanced in vitro stimulating effect of VEGF on proliferation of the endothelial cells. Serum level of interleukin-6 was gradually decreased, whereas fibrinolytic activity of serum, reflected by t-PA/PAI-1 ratio, increased. Serum samples obtained from the studied patients suppressed oxidative stress and release of interleukin-6 in endothelial cells maintained in in vitro culture. Conclusion: Sulodexide reduces intravascular inflammation and suppresses inflammatory reaction in the endothelial cells; both effects are desirable in patients with peripheral vascular disease.",
keywords = "Endothelium, Inflammation, Peripheral vascular disease, Sulodexide",
author = "A. Połubińska and R. Staniszewski and E. Baum and K. Sumińska-Jasińska and A. Brȩborowicz",
year = "2013",
month = "12",
day = "1",
doi = "10.2478/ams-2013-0016",
language = "English (US)",
volume = "58",
pages = "304--310",
journal = "Advances in Medical Sciences",
issn = "1896-1126",
publisher = "Medical University of Bialystok",
number = "2",

}

TY - JOUR

T1 - Sulodexide modifies intravascular homeostasis what affects function of the endothelium

AU - Połubińska, A.

AU - Staniszewski, R.

AU - Baum, E.

AU - Sumińska-Jasińska, K.

AU - Brȩborowicz, A.

PY - 2013/12/1

Y1 - 2013/12/1

N2 - Purpose: Sulodexide is a mixture of heparin and dermatan sulphate which has an antithrombotic action. It was shown that it has also direct effect on the endothelial cells. We tested the effect of sulodexide on the intravascular homeostasis in patients with peripheral vascular disease. Methods: Sulodexide was infused iv. at a dose of 1200 Lipoprotein Lipase Releasing Units (LRU) in 10 patients with peripheral vascular disease. Blood samples were collected before the infusion and 1, 6 and 24 hours after the infusion. Inflammatory and fibrinolytic parameters were studied in the collected serum samples. Additionally, ex-vivo effect of the serum samples on in vitro function of the endothelial cells was studied. Results: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium. We found that HGF enhanced in vitro stimulating effect of VEGF on proliferation of the endothelial cells. Serum level of interleukin-6 was gradually decreased, whereas fibrinolytic activity of serum, reflected by t-PA/PAI-1 ratio, increased. Serum samples obtained from the studied patients suppressed oxidative stress and release of interleukin-6 in endothelial cells maintained in in vitro culture. Conclusion: Sulodexide reduces intravascular inflammation and suppresses inflammatory reaction in the endothelial cells; both effects are desirable in patients with peripheral vascular disease.

AB - Purpose: Sulodexide is a mixture of heparin and dermatan sulphate which has an antithrombotic action. It was shown that it has also direct effect on the endothelial cells. We tested the effect of sulodexide on the intravascular homeostasis in patients with peripheral vascular disease. Methods: Sulodexide was infused iv. at a dose of 1200 Lipoprotein Lipase Releasing Units (LRU) in 10 patients with peripheral vascular disease. Blood samples were collected before the infusion and 1, 6 and 24 hours after the infusion. Inflammatory and fibrinolytic parameters were studied in the collected serum samples. Additionally, ex-vivo effect of the serum samples on in vitro function of the endothelial cells was studied. Results: Infusion of sulodexide caused acute and transient peak of the Hepatocyte Growth Factor (HGF) concentration in blood and decrease of the Vascular Endothelial Growth Factor (VEGF) level, what, as we found in in vitro experiments, was due to adsorption of VEGF to endothelium. We found that HGF enhanced in vitro stimulating effect of VEGF on proliferation of the endothelial cells. Serum level of interleukin-6 was gradually decreased, whereas fibrinolytic activity of serum, reflected by t-PA/PAI-1 ratio, increased. Serum samples obtained from the studied patients suppressed oxidative stress and release of interleukin-6 in endothelial cells maintained in in vitro culture. Conclusion: Sulodexide reduces intravascular inflammation and suppresses inflammatory reaction in the endothelial cells; both effects are desirable in patients with peripheral vascular disease.

KW - Endothelium

KW - Inflammation

KW - Peripheral vascular disease

KW - Sulodexide

UR - http://www.scopus.com/inward/record.url?scp=84896822941&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84896822941&partnerID=8YFLogxK

U2 - 10.2478/ams-2013-0016

DO - 10.2478/ams-2013-0016

M3 - Article

VL - 58

SP - 304

EP - 310

JO - Advances in Medical Sciences

JF - Advances in Medical Sciences

SN - 1896-1126

IS - 2

ER -